Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Saphire, Erica Ollmann"" wg kryterium: Autor


Tytuł:
Identification of mouse CD4 T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers.
Autorzy:
Bricio-Moreno, Laura
de Albuquerque, Juliana Barreto
Neary, Jake M.
Thao Nguyen
Kuhn, Lucy F.
YeePui Yeung
Hastie, Kathryn M.
Landeras-Bueno, Sara
Olmedillas, Eduardo
Hariharan, Chitra
Nathan, Anusha
Getz, Matthew A.
Gayton, Alton C.
Khatri, Ashok
Gaiha, Gaurav D.
Saphire, Erica Ollmann
Luster, Andrew D.
Moon, James J.
Pokaż więcej
Źródło:
Frontiers in Immunology; 2024, p1-10, 10p
Czasopismo naukowe
Tytuł:
The C-terminus of Sudan ebolavirus VP40 contains a functionally important CXnC motif, a target for redox modifications.
Autorzy:
Werner, Anke-Dorothee (AUTHOR)
Schauflinger, Martin (AUTHOR)
Norris, Michael J. (AUTHOR)
Klüver, Michael (AUTHOR)
Trodler, Anna (AUTHOR)
Herwig, Astrid (AUTHOR)
Brandstädter, Christina (AUTHOR)
Dillenberger, Melissa (AUTHOR)
Klebe, Gerhard (AUTHOR)
Heine, Andreas (AUTHOR)
Saphire, Erica Ollmann (AUTHOR)
Becker, Katja (AUTHOR)
Becker, Stephan (AUTHOR)
Pokaż więcej
Źródło:
Structure. Sep2023, Vol. 31 Issue 9, p1038-1038. 1p.
Czasopismo naukowe
Tytuł:
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
Autorzy:
Gunn, Bronwyn M.
McNamara, Ryan P.
Wood, Lianna
Taylor, Sabian
Devadhasan, Anush
Guo, Wenyu
Das, Jishnu
Nilsson, Avlant
Shurtleff, Amy
Dubey, Sheri
Eichberg, Michael
Suscovich, Todd J.
Saphire, Erica Ollmann
Lauffenburger, Douglas
Coller, Beth-Ann
Simon, Jakub K.
Alter, Galit
Pokaż więcej
Źródło:
In Cell Reports 25 April 2023 42(4)
Czasopismo naukowe
Tytuł:
Coronavirus Immunotherapeutic Consortium Database.
Autorzy:
Mahita J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Ha B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Gambiez A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Schendel SL; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Li H; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Hastie KM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Dennison SM; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Li K; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Kuzmina N; Department of Pathology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-0609, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-1019, USA.
Periasamy S; Department of Pathology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-0609, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-1019, USA.
Bukreyev A; Department of Pathology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-0609, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-1019, USA.; Galveston National Laboratory, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77550, USA.
Munt JE; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, 135 Dauer Drive, 2101 McGavran-Greenberg Hall,CB #7435, Chapel Hill, NC 27599-7435, USA.
Osei-Twum M; Nexelis, a Q2 Solutions Company, 525 Boulevard Cartier Ouest, Laval, Quebec H7V 3S8, Canada.
Atyeo C; Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambrige, MA 02139-3583, USA.
Overton JA; Knocean Inc., 107 Quebec Ave. Toronto, Ontario, M6P 2T3, Canada.
Vita R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Guzman-Orozco H; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Mendes M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Kojima M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Halfmann PJ; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI 53711, USA.
Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI 53711, USA.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan.
Alter G; Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambrige, MA 02139-3583, USA.
Gagnon L; Nexelis, a Q2 Solutions Company, 525 Boulevard Cartier Ouest, Laval, Quebec H7V 3S8, Canada.
Baric RS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, 135 Dauer Drive, 2101 McGavran-Greenberg Hall,CB #7435, Chapel Hill, NC 27599-7435, USA.; Department of Microbiology and Immunology, School of Medicine, 125 Marson Farm Road, Chapel Hill, NC 27599-7290, USA.
Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Germann T; Carterra Inc., 825 N. 300 W.Ste, C309, Salt Lake City, UT 84103, USA.
Bedinger D; Carterra Inc., 825 N. 300 W.Ste, C309, Salt Lake City, UT 84103, USA.
Greenbaum JA; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, 9500 Gilman Drive MC 0507, La Jolla 92093-0507, California.
Peters B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, 9500 Gilman Drive MC 0507, La Jolla 92093-0507, California.
Pokaż więcej
Źródło:
Database : the journal of biological databases and curation [Database (Oxford)] 2023 Feb 10; Vol. 2023.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Humans ; SARS-CoV-2 ; Antibodies, Viral ; Immunotherapy
Czasopismo naukowe
Tytuł:
Antibodies as drugs-a Keystone Symposia report.
Autorzy:
Cable J; PhD Science Writer, New York, New York, USA.
Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA.
Hayday AC; Peter Gorer Department of Immunobiology, King's College London, London, UK.; Cancer Research UK Cancer Immunotherapy Accelerator, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Wiltshire TD; Mayo Clinic, Rochester, Minnesota, USA.
Mousa JJ; Department of Infectious Diseases and Center for Vaccines and Immunology, College of Veterinary Medicine, Athens, Georgia, USA.; Department of Biochemistry and Molecular Biology, Franklin College of Arts and Sciences, University of Georgia, Athens, Georgia, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Humphreys DP; Protein Sciences, UCB Pharma, Berkshire, UK.
Breij ECW; Translational Research and Precision Medicine, Genmab BV, Utrecht, the Netherlands.
Bruhns P; Institut Pasteur, Université de Paris, Unit of Antibodies in Therapy and Pathology, Paris, France.
Broketa M; Institut Pasteur, Université de Paris, Unit of Antibodies in Therapy and Pathology, Paris, France.
Furuya G; Department of Preventive Medicine and Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Mahévas M; Service de Médecine Interne, Centre de Référence des Cytopénies Auto-immunes de l'adulte, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
Carfi A; Moderna Inc., Cambridge, Massachusetts, USA.; Department of Pathology, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Cantaert T; Immunology Unit, Institut Pasteur du Cambodge, The Pasteur Network, Phnom Penh, Cambodia.
Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Tripathi P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Davis JH; Invenra, Inc, Madison, Wisconsin, USA.
Brewis N; F-star Therapeutics Ltd., Cambridge, UK.
Keyt BA; IGM Biosciences, Inc., Mountainview, California, USA.
Fennemann FL; Lava Therapeutics, Utrecht, the Netherlands.
Dussupt V; Emerging Infectious Diseases Branch, U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Sivasubramanian A; Computational Biology, Adimab, Palo Alto, California, USA.
Kim PM; Department of Molecular Genetics, Donnelly Centre for Cellular and Biomolecular Research, Toronto, Ontario, Canada.; Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
Rawi R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Richardson E; Department of Statistics, University of Oxford, Oxford, UK.
Leventhal D; Generate Biomedicines, Somerville, Massachusetts, USA.
Wolters RM; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Geuijen CAW; Merus N.V., Utrecht, the Netherlands.
Sleeman MA; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
Pengo N; Mabylon AG, Schlieren, Switzerland.
Donnellan FR; University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2023 Jan; Vol. 1519 (1), pp. 153-166. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bispecific*/therapeutic use
Humans ; Immunotherapy
Czasopismo naukowe
Tytuł:
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Autorzy:
Cable J; PhD Science Writer, New York, New York, USA.
Fauci A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Günther S; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
Bente DA; University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, USA.; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune, India.
Madoff LC; Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester, Massachusetts, USA.
Wang LF; Duke-NUS Medical School, Singapore.
Arora RK; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
Van Kerkhove M; World Health Organization, Geneva, Switzerland.
Chu MC; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
Jaenisch T; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
Epstein JH; EcoHealth Alliance, New York, New York, USA.
Frost SDW; Microsoft Research, Redmond, Washington, USA.
Bausch DG; FIND, the global alliance for diagnostics, Geneva, Switzerland.
Hensley LE; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Bergeron É; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Gunn MD; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Geisbert TW; University of Manitoba, Winnipeg, Manitoba, Canada.; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
Krammer F; Department of Microbiology and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
de Wit E; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Nordenfelt P; Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Corbett KS; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Branco LM; Zalgen Labs, Germantown, Maryland, USA.
Baize S; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Lyon, France.; INSERM, Ecole Normale Supérieure de Lyon, Université de Lyon, Lyon, France.
van Doremalen N; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Krieger MA; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation - Paraná, Curitiba, Brazil.; Integrated Translational Program in Chagas Disease from Fiocruz (Fio-Chagas), Oswaldo Cruz Foundation - Rio de Janeiro, Rio de Janeiro, Brazil.
Clemens SAC; Oxford Vaccine Group, Oxford University, Oxford, UK.; Institute for Global Health, University of Siena, Siena, Italy.
Hesselink R; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Hartman D; Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2022 Dec; Vol. 1518 (1), pp. 209-225. Date of Electronic Publication: 2022 Oct 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Ebolavirus*
Humans ; Pandemics ; Disease Outbreaks
Czasopismo naukowe
Tytuł:
Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey
Autorzy:
Worwa, GabriellaAff1, IDs42003022041582_cor1
Cooper, Timothy K.
Yeh, StevenAff2, Aff3
Shantha, Jessica G.
Hischak, Amanda M. W.
Klim, Sarah E.
Byrum, Russell
Kurtz, Jonathan R.
Anthony, Scott M.
Aiosa, Nina M.
Ragland, Danny
Lee, Ji Hyun
Claire, Marisa St.
Davis, Carl
Ahmed, Rafi
Holbrook, Michael R.
Kuhn, Jens H.
Saphire, Erica Ollmann
Crozier, IanAff1, Aff6, IDs42003022041582_cor19
Pokaż więcej
Źródło:
Communications Biology. 5(1)
Czasopismo naukowe
Tytuł:
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Autorzy:
Chang, Matthew R.
Tomasovic, Luke
Kuzmina, Natalia A.Aff2, Aff3, Aff4
Ronk, Adam J.Aff2, Aff3, Aff4
Byrne, Patrick O.
Johnson, Rebecca
Storm, Nadia
Olmedillas, Eduardo
Hou, Yixuan J.
Schäfer, Alexandra
Leist, Sarah R.
Tse, Longping V.
Ke, HanzhongAff1, Aff9
Coherd, Christian
Nguyen, Katrina
Kamkaew, Maliwan
Honko, Anna
Zhu, QuanAff1, Aff9
Alter, Galit
Saphire, Erica Ollmann
McLellan, Jason S.
Griffiths, Anthony
Baric, Ralph S.
Bukreyev, AlexanderAff2, Aff3, Aff4
Marasco, Wayne A.Aff1, Aff9, IDs41467022330304_cor25
Pokaż więcej
Źródło:
Nature Communications. 13(1)
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies